1979, ISBN 0815132778, 168
Book
BMC Neuroscience, ISSN 1471-2202, 08/2017, Volume 18, Issue S1, pp. 59 - 79
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2000, Volume 44, Issue 6, pp. 1667 - 1673
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
CELLS | CORECEPTOR | IN-VIVO | HIV-1 ENTRY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | CCR5 | EXPRESSION | PROGRESSION | Anti-HIV Agents - administration & dosage | Animals | Heterocyclic Compounds - administration & dosage | Heterocyclic Compounds - adverse effects | Receptors, CXCR4 - antagonists & inhibitors | Anti-HIV Agents - adverse effects | Anti-HIV Agents - pharmacokinetics | Humans | Injections, Subcutaneous | Heterocyclic Compounds - pharmacokinetics | Mice | AMD-3100 | chemokine receptors | Antiviral Agents
CELLS | CORECEPTOR | IN-VIVO | HIV-1 ENTRY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | CCR5 | EXPRESSION | PROGRESSION | Anti-HIV Agents - administration & dosage | Animals | Heterocyclic Compounds - administration & dosage | Heterocyclic Compounds - adverse effects | Receptors, CXCR4 - antagonists & inhibitors | Anti-HIV Agents - adverse effects | Anti-HIV Agents - pharmacokinetics | Humans | Injections, Subcutaneous | Heterocyclic Compounds - pharmacokinetics | Mice | AMD-3100 | chemokine receptors | Antiviral Agents
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 10/2004, Volume 37, Issue 2, pp. 1253 - 1262
AMD3100 is a CXCR4 receptor inhibitor with anti–HIV-1 activity in vitro. We tested the safety, pharmacokinetics, and antiviral effect of AMD3100 administered...
Anti-retroviral HIV | Chemokine binding inhibitor | CXCR4 antagonist | CORECEPTOR CXCR4 | INFECTIOUS DISEASES | chemokine binding inhibitor | ANTAGONIST | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | IN-VIVO | anti-retroviral HIV | CHEMOKINE RECEPTOR | TYPE-1 | CCR5 | BIOLOGICAL PHENOTYPE | VIRAL ENTRY | DISEASE PROGRESSION | Drug Administration Schedule | HIV-1 - drug effects | Receptors, CXCR4 - antagonists & inhibitors | Anti-HIV Agents - adverse effects | Humans | Treatment Outcome | HIV-1 - genetics | Receptors, CXCR4 - metabolism | HIV-1 - physiology | Heterocyclic Compounds - adverse effects | Anti-HIV Agents - pharmacokinetics | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Heterocyclic Compounds - pharmacokinetics | Heterocyclic Compounds - therapeutic use | HIV Infections - metabolism | Antiviral agents | Care and treatment | Antibiotics | HIV patients | Dosage and administration | Research | Chemokines
Anti-retroviral HIV | Chemokine binding inhibitor | CXCR4 antagonist | CORECEPTOR CXCR4 | INFECTIOUS DISEASES | chemokine binding inhibitor | ANTAGONIST | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | IN-VIVO | anti-retroviral HIV | CHEMOKINE RECEPTOR | TYPE-1 | CCR5 | BIOLOGICAL PHENOTYPE | VIRAL ENTRY | DISEASE PROGRESSION | Drug Administration Schedule | HIV-1 - drug effects | Receptors, CXCR4 - antagonists & inhibitors | Anti-HIV Agents - adverse effects | Humans | Treatment Outcome | HIV-1 - genetics | Receptors, CXCR4 - metabolism | HIV-1 - physiology | Heterocyclic Compounds - adverse effects | Anti-HIV Agents - pharmacokinetics | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Heterocyclic Compounds - pharmacokinetics | Heterocyclic Compounds - therapeutic use | HIV Infections - metabolism | Antiviral agents | Care and treatment | Antibiotics | HIV patients | Dosage and administration | Research | Chemokines
Journal Article
2003, Rural studies series of the Rural Sociological Society, ISBN 0271022426, ix, 513
Book
09/2019
Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred...
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | WINE | HYGIENE | ENZYMOLOGY | MICROORGANISMS OR ENZYMES | MEDICAL OR VETERINARY SCIENCE | MICROBIOLOGY | HUMAN NECESSITIES | BEER | MUTATION OR GENETIC ENGINEERING | SPIRITS | COMPOSITIONS THEREOF | PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | BIOCHEMISTRY | CULTURE MEDIA | CHEMISTRY | VINEGAR
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | WINE | HYGIENE | ENZYMOLOGY | MICROORGANISMS OR ENZYMES | MEDICAL OR VETERINARY SCIENCE | MICROBIOLOGY | HUMAN NECESSITIES | BEER | MUTATION OR GENETIC ENGINEERING | SPIRITS | COMPOSITIONS THEREOF | PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | BIOCHEMISTRY | CULTURE MEDIA | CHEMISTRY | VINEGAR
Patent
08/2019
Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred...
WINE | SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | ENZYMOLOGY | MICROORGANISMS OR ENZYMES | MEDICAL OR VETERINARY SCIENCE | MICROBIOLOGY | HUMAN NECESSITIES | BEER | MUTATION OR GENETIC ENGINEERING | SPIRITS | COMPOSITIONS THEREOF | PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | BIOCHEMISTRY | CULTURE MEDIA | CHEMISTRY | VINEGAR
WINE | SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | ENZYMOLOGY | MICROORGANISMS OR ENZYMES | MEDICAL OR VETERINARY SCIENCE | MICROBIOLOGY | HUMAN NECESSITIES | BEER | MUTATION OR GENETIC ENGINEERING | SPIRITS | COMPOSITIONS THEREOF | PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS | METALLURGY | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | BIOCHEMISTRY | CULTURE MEDIA | CHEMISTRY | VINEGAR
Patent
British Journal of Anaesthesia, ISSN 0007-0912, 10/2018, Volume 121, Issue 4, pp. 730 - 738
Cancellation of planned surgery impacts substantially on patients and health systems. This study describes the incidence and reasons for cancellation of...
operating room management | Health Services Research | medical resource utilisation | surgery | NEED | VALIDATION | ANESTHESIOLOGY | CRITICAL-CARE | CANCELLATIONS | ELECTIVE SURGERY
operating room management | Health Services Research | medical resource utilisation | surgery | NEED | VALIDATION | ANESTHESIOLOGY | CRITICAL-CARE | CANCELLATIONS | ELECTIVE SURGERY
Journal Article